Maravai Lifesciences Holdings (MRVI) Work In Process (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Work In Process of $9.0 million for Q1 2026, down 9.44% year-over-year from $9.9 million in Q1 2025, and up 22.7% quarter-over-quarter from $7.3 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Work In Process (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Work In Process history runs 7 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- In Q1 2026, Work In Process fell 9.44% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $9.0 million (down 9.44% YoY), while the FY2025 annual figure was $7.3 million, down 27.18% from the prior year.
- Work In Process for Q1 2026 stood at $9.0 million, up from $7.3 million in the prior quarter.
- The five-year high for Work In Process was $30.6 million in Q3 2022, with the low at $7.3 million in Q4 2025.
- The 5-year median for Work In Process is $12.2 million (2023), against an average of $15.0 million.
- The sharpest annual moves came in 2022 and 2023: Work In Process soared 30.73% in 2022, then tumbled 60.06% in 2023.
- Maravai Lifesciences Holdings' Work In Process stood at $22.0 million in 2022, then slumped by 42.23% to $12.7 million in 2023, then declined by 20.74% to $10.0 million in 2024, then fell by 27.18% to $7.3 million in 2025, then increased by 22.7% to $9.0 million in 2026.
- Business Quant data shows MRVI's Work In Process at $9.0 million in Q1 2026, $7.3 million in Q4 2025, and $9.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.90 Mn |
| Mar 31, 2026 | 8.98 Mn |
| Dec 31, 2025 | 7.32 Mn |
| Sep 30, 2025 | 9.70 Mn |
| Jun 30, 2025 | 10.52 Mn |
| Mar 31, 2025 | 9.92 Mn |
| Dec 31, 2024 | 10.05 Mn |
| Sep 30, 2024 | 10.75 Mn |
| Jun 30, 2024 | 11.02 Mn |
| Mar 31, 2024 | 12.53 Mn |
| Dec 31, 2023 | 12.68 Mn |
| Sep 30, 2023 | 12.21 Mn |
| Jun 30, 2023 | 14.50 Mn |
| Mar 31, 2023 | 22.17 Mn |
| Dec 31, 2022 | 21.95 Mn |
| Sep 30, 2022 | 30.57 Mn |
| Jun 30, 2022 | 30.07 Mn |
| Mar 31, 2022 | 20.55 Mn |
| Dec 31, 2021 | 21.38 Mn |
| Sep 30, 2021 | 25.43 Mn |